AstraZeneca vs Boeing: Founders, CEOs and History

Company facts

Founders

CEOs and their tenures

Timeline: AstraZeneca and Boeing side by side

1. 1913AstraZeneca

   Astra AB Founded in Södertälje, Sweden

   400 doctors and apothecaries establish Astra AB to manufacture pharmaceuticals for the Swedish market, creating the foundation for what would become one of Europe's largest drug companies.

2. 1916Boeing

   Pacific Aero Products Company Incorporated

   William Boeing incorporates Pacific Aero Products Co. on July 15, 1916 in Seattle, a month after the B&W seaplane he built with George Conrad Westervelt first flew from Lake Union on June 15.

3. 1917Boeing

   Renamed The Boeing Airplane Company; First Military Contract

   The company is renamed The Boeing Airplane Company in April 1917 following co-founder George Westervelt's return to active Navy duty, and secures its first meaningful military contract when the U.S. Navy orders the improved Model C floatplane.

4. 1927Boeing

   Boeing Air Transport Wins San Francisco-Chicago Airmail Route

   Boeing forms Boeing Air Transport and wins the U.S. Post Office airmail contract for the San Francisco to Chicago route, the most commercially valuable domestic airmail route, initiating Boeing's involvement in commercial aviation beyond manufacturing.

5. 1933Boeing

   Boeing 247 Introduced as the First Modern Airliner

   Boeing introduces the Model 247, widely recognized as the world's first modern commercial airliner, featuring all-metal construction, retractable landing gear, a cantilevered wing, and variable-pitch propellers.

6. 1954Boeing

   Dash 80 Jet Prototype First Flies

   The 367-80, or Dash 80, first flies on July 15, 1954, the company's 38th anniversary. Funded with about $16 million of Boeing's own money, it leads to the KC-135 tanker for the Air Force and the 707 airliner, which enters service with Pan Am in 1958.

7. 1969Boeing

   Boeing 747 Jumbo Jet Makes First Flight

   The 747, the first wide-body jetliner, first flies on February 9, 1969 and enters service with Pan Am in January 1970.

8. 1993AstraZeneca

   Zeneca Group Spun Off from ICI

   Imperial Chemical Industries demerges its pharmaceuticals and agrochemicals businesses to form Zeneca Group PLC, with initial products including Zestril, Nolvadex, and Zoladex generating approximately $3.2 billion in annual sales.

9. 1994Boeing

   Boeing 777 First Flight

   The Boeing 777, the world's largest twin-engine commercial aircraft and the first airliner designed entirely using computer-aided design tools without physical mock-ups, makes its inaugural flight on June 12, 1994.

10. 1997Boeing

    Boeing Merges with McDonnell Douglas

    Boeing completes its $13.3 billion acquisition of McDonnell Douglas, creating a single dominant American aerospace and defense company and ending more than two decades of three-way commercial aircraft competition.

11. 1999AstraZeneca

    Astra and Zeneca Merge to Form AstraZeneca

    The all-share merger of equals completes on 6 April 1999, creating AstraZeneca PLC.

12. 2000AstraZeneca

    Nexium Launch Replaces Prilosec

    AstraZeneca launches Nexium (esomeprazole), the single-isomer successor to Losec/Prilosec, in Europe in 2000 and in the United States in 2001 after FDA approval on 20 February 2001.

13. 2006AstraZeneca

    Acquisition of Cambridge Antibody Technology

    AstraZeneca agrees in May 2006 to buy Cambridge Antibody Technology for 1,320 pence a share, valuing the UK biotech at 702 million pounds or about $1.32 billion.

14. 2007AstraZeneca

    Acquisition of MedImmune for $15.6 Billion

    AstraZeneca acquires MedImmune for $15.6 billion, entering the biologics market and gaining the Synagis respiratory syncytial virus franchise and antibody technology platforms. The Gaithersburg facility becomes one of three global R&D centres.

15. 2009Boeing

    Boeing 787 Dreamliner First Flight

    The Boeing 787 Dreamliner, the first commercial aircraft built primarily from carbon-fiber composite materials, makes its first flight on December 15, 2009 more than two years behind its original 2007 schedule following extensive supply chain difficulties with…

16. 2012AstraZeneca

    Pascal Soriot Appointed CEO

    Pascal Soriot joins AstraZeneca as Chief Executive Officer on October 1, 2012, with a base salary of $1.4 million and a mandate to reverse declining revenue and R&D productivity through science-led investment.

17. 2014AstraZeneca

    Pfizer Hostile Takeover Rejected

    AstraZeneca's board rejects a $117 billion hostile takeover offer from Pfizer, with Soriot arguing that the undervaluation would destroy long-term shareholder value and pipeline potential.

18. 2014AstraZeneca

    Acquisition of Almirall Respiratory Portfolio

    AstraZeneca acquires the respiratory portfolio of Spanish pharmaceutical company Almirall for approximately $2.1 billion, strengthening the company's position in COPD and asthma with products including Eklira and pipeline candidates that become Breztri.

19. 2015AstraZeneca

    Tagrisso Approved for EGFR-Mutated Lung Cancer

    The FDA approves Tagrisso (osimertinib) in November 2015 for metastatic EGFR T790M mutation-positive non-small cell lung cancer, the first product from Soriot's reinvestment strategy to reach market.

20. 2017AstraZeneca

    Imfinzi Approved Based on PACIFIC Trial

    The FDA approves Imfinzi (durvalumab) for unresectable stage III non-small cell lung cancer after chemoradiation, based on PACIFIC trial data showing survival benefits.

21. 2019Boeing

    737 MAX Grounded Worldwide Following Two Fatal Crashes

    After the Lion Air Flight 610 crash in October 2018 and the Ethiopian Airlines Flight 302 crash in March 2019, which killed 346 people, regulators ground the 737 MAX worldwide.

22. 2020AstraZeneca

    COVID-19 Vaccine Development with Oxford University

    AstraZeneca partners with the University of Oxford to develop and manufacture the Vaxzevria COVID-19 vaccine, distributing billions of doses globally at nonprofit pricing during the pandemic peak.

23. 2021AstraZeneca

    Acquisition of Alexion Pharmaceuticals for $39 Billion

    AstraZeneca completes the $39 billion acquisition of Alexion on July 21, 2021, entering the rare disease market with Soliris and Ultomiris and creating a dedicated rare disease unit headquartered in Boston.

24. 2022Boeing

    Boeing Relocates Corporate Headquarters to Arlington, Virginia

    Boeing formally moves its corporate headquarters from Chicago, Illinois, to Arlington, Virginia, placing its senior executive team adjacent to the Pentagon and within close proximity to Congress and the regulatory agencies that govern both its defense and comm…

25. 2023AstraZeneca

    CinCor Pharma Acquired for up to $1.8 Billion

    AstraZeneca agrees on 9 January 2023 to acquire CinCor Pharma for up to $1.8 billion, $26 per share in cash plus a $10 per share contingent value right, to gain baxdrostat, an aldosterone synthase inhibitor for resistant hypertension.

26. 2024AstraZeneca

    Total Revenue Reaches $54.073 Billion

    AstraZeneca reports Total Revenue of $54.073 billion for fiscal year 2024, an 18% increase at actual rates and 21% at constant exchange rates, with 16 blockbuster medicines, 74 regulatory events, and 24 pipeline progression events.

27. 2024AstraZeneca

    Fusion Pharmaceuticals and Gracell Acquisitions

    AstraZeneca acquires Fusion Pharmaceuticals for $2 billion to access radiopharmaceutical technology and Gracell Biotechnologies for $1.2 billion for cell therapy manufacturing, expanding modality diversity into radiopharmaceuticals and CAR-T.

28. 2024Boeing

    Door-Plug Blowout, Machinists Strike, and Leadership Transition

    Alaska Airlines Flight 1282 experiences a door-plug blowout at 16,000 feet on January 5, triggering a FAA production cap on 737 MAX and a congressional investigation into Boeing's quality management.

29. 2025AstraZeneca

    Total Revenue Reaches $58.739 Billion

    AstraZeneca reports Total Revenue of $58.739 billion for fiscal year 2025, an 8% increase at constant exchange rates, with 16 positive Phase III readouts, 43 major market approvals, and a commitment to invest $50 billion in U.S. manufacturing by 2030.

30. 2025AstraZeneca

    EsoBiotec Acquired for Up to $1 Billion

    AstraZeneca acquires Belgian biotech EsoBiotec for up to $1 billion to access in vivo cell therapy technology, eliminating the need for ex vivo manufacturing in CAR-T therapies.

31. 2025AstraZeneca

    $50 Billion US Manufacturing and R&D Commitment

    AstraZeneca announces on 21 July 2025 that it will invest $50 billion in United States manufacturing and research by 2030, including a new Virginia facility later raised to $4.5 billion.

32. 2025Boeing

    F-47 Win, Strike in St. Louis, Spirit Buyback and a Return to Profit

    The Air Force selects Boeing's F-47 as its sixth-generation fighter in March. Boeing sells Jeppesen and other digital units to Thoma Bravo for $10.55 billion, the FAA raises the 737 cap to 42 a month in October, a 102-day strike at St.

33. 2026AstraZeneca

    Ordinary Shares Begin Trading on the NYSE

    AstraZeneca ordinary shares start trading on the New York Stock Exchange on 2 February 2026 under the ticker AZN, after the American Depositary Share programme and certain debt securities stopped trading on Nasdaq on 30 January 2026.

34. 2026AstraZeneca

    Baxfendy Approved in the US for Hypertension

    The FDA approves Baxfendy (baxdrostat) in May 2026 as the first aldosterone synthase inhibitor for hypertension, used in combination with other antihypertensives in adults who are not adequately controlled.

35. 2026AstraZeneca

    $15 Billion China Investment Through 2030

    AstraZeneca announces on 29 January 2026 that it will invest $15 billion in China through 2030 to expand manufacturing and research, in a market that is its second largest and about 12% of revenue.

36. 2026Boeing

    737-7 Certified, F/A-XX Win and a 737-10 Setback

    Backlog reaches a record $715 billion at June 30. The FAA certifies the 737-7 on August 3, then on September 28 holds 737-10 certification over a flight-management software issue. On September 29 the Navy selects Boeing to build the F/A-XX fighter.

Acquisitions

Questions about AstraZeneca vs Boeing